Other Top Large Cap Biotech Stocks
We can actually go through this exercise for a handful of other biotech marvels. Revenue is booming, pipelines are rich, stock prices are crushed. Below I quickly posted the revenue charts for a few more popular large cap biotech stocks and the sector.
Of course, further analysis is needed than a few charts, and that’s what we do at CML Pro — get into the guts of how these companies make money. But just a taste from Gilead and Celgene above, and then a smattering of other charts below for the other biotech marvels, and we can see that the focus on selling biotechs has created a wonderful opportunity.
Here are some revenue charts to breeze through:
Amgen (AMGN)
Biogen (BIIB)
Regeneron (REGN)
Taking a more holistic approach: Here are the biotechs growing revenue the fastest over the last year ranked in one chart:
Thanks for reading.
More from Ophir:  “Facebook, Apple, And The Best Tech Companies In The World“
Read more from Ophir on CMLviz.com.
Twitter: Â @OphirGottlieb
Author has positions in mentioned securities at the time of publication. Â Any opinions expressed herein are solely those of the author, and do not in any way represent the views or opinions of any other person or entity.
